Tag: track

Tokyo, Japan and Cambridge, UK, 2 June 2026 – Nxera Pharma Co., Ltd. (“Nxera” or the “Company”)　 announces that the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea has granted Orphan Drug Designation (ODD) and Global Innovative Products on Fast Track (GIFT) designation to vamorolone for the treatment of Duchenne muscular dystrophy (DMD). The Company plans to submit a Marketing Authorization Application (MAA) for vamorolone in South Korea during 2026.

All amounts in Canadian dollars unless otherwise stated.

HOUSTON, June 01, 2026 (GLOBE NEWSWIRE) -- Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) filed its definitive proxy statement (the “Proxy Statement”) with the Securities and Exchange Commission (the “SEC”) on April 21, 2026, in connection with Weatherford’s proposal to Redomesticate from Ireland to the United States of America (the “U.S.”). Capitalized terms used herein but not defined have the meanings set forth in the Proxy Statement.

Learn how MemeToro uses AI agents, memecoin analytics, DeFi trading, and prediction markets to help beginners discover the best crypto presale opportunities early

NEW CANAAN, Conn., June 01, 2026 (GLOBE NEWSWIRE) -- NewLake Capital Partners, Inc. (OTCQX: NLCP) (“NewLake or “the Company”), a leading provider of real estate capital to state-licensed cannabis operators, today announced that management will participate in the following June 2026 conferences.

AB “Ignitis grupė” (hereinafter – the Group) has announced a Group CEO selection, as the second term of the current CEO, Darius Maikštėnas, ends on February 28, 2027. According to the Law on Companies of the Republic of Lithuania, the same person may be appointed as the CEO of a state-owned company for no more than two consecutive terms.

AB “Ignitis grupė” (hereinafter – the Group) has announced a Group CEO selection, as the second term of the current CEO, Darius Maikštėnas, ends on February 28, 2027. According to the Law on Companies of the Republic of Lithuania, the same person may be appointed as the CEO of a state-owned company for no more than two consecutive terms.